ARTICLE | Clinical News
Diltiazem: Completed Phase III enrollment
January 9, 2012 8:00 AM UTC
Ventrus completed enrollment of 465 patients with anal fissures in a double-blind, placebo-controlled, European Phase III trial evaluating 2% and 4% diltiazem cream for 8 weeks. Ventrus has North Amer...